World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
141
Citations
75460
World Ranking
1622
National Ranking
944

Paul A. Bunn publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul A. Bunn sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 778 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul A. Bunn D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul A. Bunn sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 141 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2005 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Paul A. Bunn is affiliated with the University of Colorado Boulder in the United States and specializes in the field of Medicine with a focus on oncology and pulmonary research.

Their research contributions primarily cover the following main topics:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • COVID-19 and healthcare impacts
  • Neuroendocrine Tumor Research Advances

Their work spans multiple subfields including:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Epidemiology

Frequent co-authors in their publications include:

  • Fred R. Hirsch
  • Ignacio I. Wistuba
  • Mark G. Kris
  • Philip C. Mack
  • David P. Carbone

They have published extensively in several prominent venues with the majority of their work appearing in:

  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Clinical Lung Cancer
  • Nature Medicine
  • Annals of Oncology

Among their recent papers are:

  • "IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy," 2020, Journal of Thoracic Oncology
  • "Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions," 2023, CA A Cancer Journal for Clinicians
  • "Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial," 2022, Nature Medicine
  • "Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy," 2023, Journal of Clinical Oncology
  • "Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution," 2020, Molecular Oncology

Paul A. Bunn has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 2005.

Best Publications

  • Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

    Bernard J. Poiesz;Francis W. Ruscetti;Adi F. Gazdar;Paul A. Bunn

  • Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

    Nasser Hanna;Frances A. Shepherd;Frank V. Fossella;Jose R. Pereira

  • Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer

    Federico Cappuzzo;Fred R. Hirsch;Elisa Rossi;Stefania Bartolini

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

    Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Michael V. Di Maria

  • Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

    Karen Kelly;John Crowley;Paul A. Bunn;Cary A. Presant

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

    T. Lindmo;E. Boven;F. Cuttitta;J. Fedorko

  • Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer

    Fred R. Hirsch;Marileila Varella-Garcia;Paul A. Bunn;Wilbur A. Franklin

  • Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study

    Fred R. Hirsch;Marileila Varella-Garcia;Jason McCoy;Howard West

  • Small-cell lung cancer: what we know, what we need to know and the path forward

    Adi F. Gazdar;Paul A. Bunn;John D. Minna

  • Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

    Nasser Hanna;Paul A. Bunn;Corey Langer;Lawrence Einhorn

  • Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology

    Fred R. Hirsch;Wilbur A. Franklin;Adi F. Gazdar;Paul A. Bunn

  • Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    Andrew J. Weickhardt;Benjamin Scheier;Joseph Malachy Burke;Gregory Gan

  • Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.

    Bunn Pa;Lamberg Si

  • Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23)

    J. Whang-Peng;C. S. Kao-Shan;E. C. Lee;P. A. Bunn

  • CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival.

    John L. Nugent;Paul A. Bunn;Mary J. Matthews;Daniel C. Ihde

  • Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

    Adi F. Gazdar;Desmond N. Carney;Desmond N. Carney;Paul A. Bunn;Paul A. Bunn;Edward K. Russell;Edward K. Russell

  • New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.

    Paul A. Bunn;Karen Kelly

  • Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

    Samir E. Witta;Robert M. Gemmill;Fred R. Hirsch;Christopher D. Coldren

Frequent Co-Authors

Wilbur A. Franklin
Wilbur A. Franklin University of Colorado Denver
John D. Minna
John D. Minna The University of Texas Southwestern Medical Center
Fred R. Hirsch
Fred R. Hirsch Mount Sinai Hospital
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Robert C. Doebele
Robert C. Doebele University of Colorado Denver
Bruce E. Johnson
Bruce E. Johnson Harvard University
D. Ross Camidge
D. Ross Camidge University of Colorado Anschutz Medical Campus
David J. Kwiatkowski
David J. Kwiatkowski Brigham and Women's Hospital
Anna E. Barón
Anna E. Barón University of Colorado Anschutz Medical Campus
Daniel C. Ihde
Daniel C. Ihde National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can help you fast-track your career in healthcare and medicine. For nursing professionals seeking advanced roles, affordable dnp programs provide a cost-effective way to earn a Doctor of Nursing Practice degree and move into leadership or specialized clinical positions.

Entry-level nursing remains a popular and rewarding pathway. If you’re looking to start quickly, lpn programs offer accelerated training to become a Licensed Practical Nurse, combining flexibility with the practical skills needed in many healthcare settings.

There is also growing demand for mental health practitioners. By enrolling in online psych np programs, you can specialize in psychiatric mental health and help address the increasing need for mental health services in the USA.

Those interested in the administrative side of healthcare will find options like healthcare administration degrees. These programs teach essential leadership skills and open doors to a variety of non-clinical roles in hospitals, clinics, and health systems.

Best Scientists Citing Paul A. Bunn

Trending Scientists

Recently Published Articles